Boditech Med Inc. (KOSDAQ:206640)
9,600.00
+80.00 (0.84%)
Sep 11, 2026, 3:30 PM KST
Boditech Med Market Cap
Boditech Med has a market cap or net worth of 208.4 billion as of September 11, 2026. Its market cap has decreased by -34.20% in one year.
Market Cap
208.40B
Enterprise Value
187.44B
Revenue
174.78B
Ranking
n/a
PE Ratio
8.00
Stock Price
9,600.00
ChartMarket Cap Chart
Since September 1, 2015, Boditech Med's market cap has increased from 28.15B to 208.40B, an increase of 640.25%. That is a compound annual growth rate of 19.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 208.40B | -27.08% |
| Dec 30, 2025 | 285.80B | -22.50% |
| Dec 30, 2024 | 368.76B | -18.12% |
| Dec 28, 2023 | 450.36B | 100.01% |
| Dec 29, 2022 | 225.17B | -41.09% |
| Dec 30, 2021 | 382.21B | -29.94% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| DRTECH | 420.72B |
| Samyang Biopharm | 370.31B |
| Curexo | 328.84B |
| ToolGen | 304.49B |
| Value Added Technology | 266.63B |
| JETEMA, | 249.45B |
| Vieworks | 228.83B |
| Bio Plus | 204.93B |